Back to companies

Ascendis Pharma AS (Ascendis Pharma) is a biopharmaceutical company that focuses on developing drugs for endocrinology and oncology indications. It is investigating TransCon hGH, a long-acting human growth hormone prodrug targeting GHD (growth hormone deficiency); TransCon PTH drug to treat hypoparathyroidism by restoring physiologic levels of PTH (parathyroid hormone); and TransCon CNP, a CNP (C-type natriuretic peptide) drug against achondroplasia (ACH). It is also evaluating TransCon TLR (toll-like receptor) 7/8 agonist, and TransCon IL-2 β/γ, an interleukin-2 variant that activates the IL-2 receptor beta/gamma (IL-2Rβ/γ) for the treatment of cancer. Ascendis Pharma utilizes its proprietary TransCon technology platform to develop its drugs. The company has its operations in the US, Germany and Denmark. Ascendis Pharma is headquartered in Copenhagen, Denmark.

Headquarters Denmark

Address Tuborg Boulevard 12, Hellerup, 2900


No of Employees 639

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange ASND (NASD)

Revenue (2020) $9.2M 11.9% (2020 vs 2019)

EPS XXX

Net Income (2020) XXX 8.4% (2020 vs 2019)

Market Cap* $5.1B

Net Profit Margin (2020) XXX 18.2% (2020 vs 2019)

   

* As of and is in US$

Access premium data and analytics for Ascendis Pharma AS

60+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Ascendis Pharma AS’s relevant decision makers and contact details.

20+

Clinical Trials

Determine Ascendis Pharma AS go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

16+

Pipeline Drugs

Identify which of Ascendis Pharma AS’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

5

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Marketed Drugs

Understand Ascendis Pharma AS’s commercialized product portfolio to stay one step ahead of the market.

60+

Install Base

Install Base provides the user with a holistic as well as granular level view of the product deployments of leading vendors across geographies and sectors. Using the tool users can also get an understanding of various vendors’ products or solutions deployed by a prospect.

7

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

2

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Pipeline TransCon
TransCon hGH:
Growth Hormone Deficiency
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 New Products/Services In February, the company and EBRD launched IncubatorX SME, a programme through which companies in Bulgaria, Croatia, Romania and Serbia .
2021 Regulatory Approval In August, the company received the US Food and Drug Administration approval for its SKYTROFA to treat pediatric patients.
2021 Corporate Changes/Expansions In September, the company announced its expansion in Toronto with the launch of its new design and technology studio.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Ascendis Pharma AS OPKO Health Inc Genmab AS Nektar Therapeutics Zealand Pharma AS
Headquarters Denmark United States of America Denmark United States of America Denmark
City Hellerup Miami Koebenhavn V San Francisco Soeborg
State/Province - Florida - California -
No. of Employees 639 5,767 1,309 740 345
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Michael Wolff Jensen Chairman; Chief Legal Officer; Senior Vice President Executive Board 2007 50
Albert Cha, M.D., Ph.D. Chairman Executive Board 2021 49
Jan Moller Mikkelsen President; Director; Chief Executive Officer Executive Board 2007 62
Scott T Smith Senior Vice President; Chief Financial Officer Senior Management 2016 48
Lotte Sonderbjerg Senior Vice President; Chief Administrative Officer Senior Management 2007 60
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer